Literature DB >> 25240596

Multifunctional nanoparticle-EpCAM aptamer bioconjugates: a paradigm for targeted drug delivery and imaging in cancer therapy.

Manasi Das1, Wei Duan2, Sanjeeb K Sahoo3.   

Abstract

The promising proposition of multifunctional nanoparticles for cancer diagnostics and therapeutics has inspired the development of theranostic approach for improved cancer therapy. Moreover, active targeting of drug carrier to specific target site is crucial for providing efficient delivery of therapeutics and imaging agents. In this regard, the present study investigates the theranostic capabilities of nutlin-3a loaded poly (lactide-co-glycolide) nanoparticles, functionalized with a targeting ligand (EpCAM aptamer) and an imaging agent (quantum dots) for cancer therapy and bioimaging. A wide spectrum of in vitro analysis (cellular uptake study, cytotoxicity assay, cell cycle and apoptosis analysis, apoptosis associated proteins study) revealed superior therapeutic potentiality of targeted NPs over other formulations in EpCAM expressing cells. Moreover, our nanotheranostic system served as a superlative bio-imaging modality both in 2D monolayer culture and tumor spheroid model. Our result suggests that, these aptamer-guided multifunctional NPs may act as indispensable nanotheranostic approach toward cancer therapy. FROM THE CLINICAL EDITOR: This study investigated the theranostic capabilities of nutlin-3a loaded poly (lactide-co-glycolide) nanoparticles functionalized with a targeting ligand (EpCAM aptamer) and an imaging agent (quantum dots) for cancer therapy and bioimaging. It was concluded that the studied multifunctional targeted nanoparticle may become a viable and efficient approach in cancer therapy.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  EpCAM aptamer; Nanotheranostics; Nutlin-3a; PLGA NPs; Quantum dots

Mesh:

Substances:

Year:  2014        PMID: 25240596     DOI: 10.1016/j.nano.2014.09.002

Source DB:  PubMed          Journal:  Nanomedicine        ISSN: 1549-9634            Impact factor:   5.307


  21 in total

Review 1.  Smart Nanostructures for Cargo Delivery: Uncaging and Activating by Light.

Authors:  Mahdi Karimi; Parham Sahandi Zangabad; Soodeh Baghaee-Ravari; Mehdi Ghazadeh; Hamid Mirshekari; Michael R Hamblin
Journal:  J Am Chem Soc       Date:  2017-03-13       Impact factor: 15.419

Review 2.  Trends in the Design and Development of Specific Aptamers Against Peptides and Proteins.

Authors:  Maryam Tabarzad; Marzieh Jafari
Journal:  Protein J       Date:  2016-04       Impact factor: 2.371

3.  Interactions Between Tumor Biology and Targeted Nanoplatforms for Imaging Applications.

Authors:  Mehdi Azizi; Hassan Dianat-Moghadam; Roya Salehi; Masoud Farshbaf; Disha Iyengar; Samaresh Sau; Arun K Iyer; Hadi Valizadeh; Mohammad Mehrmohammadi; Michael R Hamblin
Journal:  Adv Funct Mater       Date:  2020-03-03       Impact factor: 18.808

Review 4.  Surface modulatable nanocapsids for targeting and tracking toward nanotheranostic delivery.

Authors:  Marie Stark; R Holland Cheng
Journal:  Pharm Pat Anal       Date:  2016-09

5.  Application of aptamers in diagnostics, drug-delivery and imaging.

Authors:  Chetan Chandola; Sheetal Kalme; Marco G Casteleijn; Arto Urtti; Muniasamy Neerathilingam
Journal:  J Biosci       Date:  2016-09       Impact factor: 2.795

Review 6.  Aptamer-Mediated Targeted Delivery of Therapeutics: An Update.

Authors:  Silvia Catuogno; Carla L Esposito; Vittorio de Franciscis
Journal:  Pharmaceuticals (Basel)       Date:  2016-11-03

Review 7.  Be Active or Not: the Relative Contribution of Active and Passive Tumor Targeting of Nanomaterials.

Authors:  Rui Li; Ke Zheng; Cai Yuan; Zhuo Chen; Mingdong Huang
Journal:  Nanotheranostics       Date:  2017-07-11

Review 8.  Aptamer-Based Therapeutic Approaches to Target Cancer Stem Cells.

Authors:  Gang Zhou; Olivier Latchoumanin; Mary Bagdesar; Lionel Hebbard; Wei Duan; Christopher Liddle; Jacob George; Liang Qiao
Journal:  Theranostics       Date:  2017-09-13       Impact factor: 11.556

9.  Enhanced anti-metastatic and anti-tumorigenic efficacy of Berbamine loaded lipid nanoparticles in vivo.

Authors:  Priyambada Parhi; Sujit Suklabaidya; Sanjeeb Kumar Sahoo
Journal:  Sci Rep       Date:  2017-07-19       Impact factor: 4.379

Review 10.  Design considerations for nanotherapeutics in oncology.

Authors:  Triantafyllos Stylianopoulos; Rakesh K Jain
Journal:  Nanomedicine       Date:  2015-08-15       Impact factor: 5.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.